Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 575124, 11 pages
http://dx.doi.org/10.1155/2014/575124
Research Article

Glycemic Control Outcomes by Gender in the Pay-for-Performance System: A Retrospective Database Analysis in Patients with Type 2 Diabetes Mellitus

1Institute of Medicine, Chung Shan Medical University, Department of Medical Management, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo N. Road, Taichung City 40201, Taiwan
2Institute of Medicine, Chung Shan Medical University, Department of Endocrinology & Metabolism, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo N. Road, Taichung City 40201, Taiwan
3Department of Health Services Administration, Chung Shan Medical University, Department of Medical Education, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo N. Road, Taichung City 40201, Taiwan
4Diabetes Education Center, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo N. Road, Taichung City 40201, Taiwan
5Department of Applied Foreign Languages, Chung Shan Medical University, Department of Medical Education, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo N. Road, Taichung City 40201, Taiwan

Received 4 May 2014; Revised 31 July 2014; Accepted 2 August 2014; Published 18 August 2014

Academic Editor: Andre P. Kengne

Copyright © 2014 Shao-Ping Yuan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Diabetes, World Health Organisation (WHO), 2012, http://www.who.int/mediacentre/factsheets/fs312/en/index.html.
  2. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. F. P. Lu, K. P. Lin, and H. K. Kuo, “Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis,” PLoS ONE, vol. 4, no. 1, Article ID e4144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. NHRI, “NHRI researcher reports on gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan,” National Health Research Institutes (NHRI), Taiwan, 2011.
  5. DOH: Statistics of the Leading Causes of Death for Men and Women in Taiwan by Age Group and Gender—2011 Annual Report, Department of Health, Executive Yuan, Yuan, Taiwan, 2012.
  6. AROC: Diabetes Taiwan, Diabetes Association of the Republic of China (DAROC), Taipei, Taiwan, 2012.
  7. “NHI: Pay-for-Performance Plans,” The Bureau of National Health Insurance, Executive Yuan, Taiwan, 2012, http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=597&WD_ID=597&webdata_id=3188.
  8. NHI: Pay-for-Performance for diabetes, The Bureau of National Health Insurance, Executive Yuan, Taiwan, 2012, http://www.nhi.gov.tw/Query/query11.aspx?menu=20&menu_id=712&webdata_id=3862&WD_ID=836.
  9. T. Lee, S. Cheng, C. Chen, and M. Lai, “A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment,” The American Journal of Managed Care, vol. 16, no. 1, pp. 65–69, 2010. View at Google Scholar · View at Scopus
  10. GHRI, The Chronic Care Model: Improving Chronic Illness Care, Group Health Research Institute (GHRI), 2012, http://www.improvingchroniccare.org/index.php?p=The_Chronic_Care_Model&s=2.
  11. ADA, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 35, supplement 1, pp. S64–S71, 2012. View at Publisher · View at Google Scholar
  12. J. A. Cramer, “A systematic review of adherence with medications for diabetes,” Diabetes Care, vol. 27, no. 5, pp. 1218–1224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. D. MacLean, B. Littenberg, and A. G. Kennedy, “Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study,” BMC Family Practice, vol. 7, article 50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. Riddle, “The underuse of insulin therapy in North America,” Diabetes/Metabolism Research and Reviews, vol. 18, supplement 3, pp. S42–S49, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Wright, A. C. F. Burden, R. B. Paisey, C. A. Cull, and R. R. Holman, “Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57),” Diabetes Care, vol. 25, no. 2, pp. 330–336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Yki-Järvinen, “Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus,” Diabetes/Metabolism Research and Reviews, vol. 18, no. 3, pp. S77–S81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. C. E. Koro, S. J. Bowlin, N. Bourgeois, and D. O. Fedder, “Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report,” Diabetes Care, vol. 27, no. 1, pp. 17–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. H. King, R. E. Aubert, and W. H. Herman, “Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections,” Diabetes Care, vol. 21, no. 9, pp. 1414–1431, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. A. F. Amos, D. J. McCarty, and P. Zimmet, “The rising global burden of diabetes and its complications: estimates and projections to the year 2010,” Diabetic Medicine, vol. 14, no. 5, pp. S7–S85, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. D. M. Nathan, J. B. Buse, M. B. Davidson et al., “Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy : aonsensus statement from the American Diabetes Association and the European Association for the Study of Diabetes,” Diabetologia, vol. 52, no. 1, pp. 17–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. T. J. Hoerger, J. E. Segel, E. W. Gregg, and J. B. Saaddine, “Is glycemic control improving in U.S. adults?” Diabetes Care, vol. 31, no. 1, pp. 81–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Yu, H. Su, S. Tsai et al., “ABC control of diabetes: survey data from National Diabetes Health Promotion Centers in Taiwan,” Diabetes Research and Clinical Practice, vol. 84, no. 2, pp. 194–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. H. Saydah, J. Fradkin, and C. C. Cowie, “Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes,” The Journal of the American Medical Association, vol. 291, no. 3, pp. 335–342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. S. C. Schoenbaum and A. L. Holmgren, The National Committee for Quality Assurance's The State of Health Care Quality 2006, vol. 1, 2006.
  25. B. M. Y. Cheung, K. L. Ong, S. S. Cherny, P. Sham, A. W. K. Tso, and K. S. L. Lam, “Diabetes Prevalence and Therapeutic Target Achievement in the United States, 1999 to 2006,” The American Journal of Medicine, vol. 122, no. 5, pp. 443–453, 2009. View at Publisher · View at Google Scholar · View at Scopus